# Ligand Pharmaceuticals Inc: Form 8-K, filed Feb 25, 2025

- Company: [Ligand Pharmaceuticals Inc](/companies/lgnd.md) (CIK 886163)
- Form: 8-K
- Filed: 2025-02-25
- Accepted by EDGAR: Feb 25, 2025, 16:02 ET
- Period: 2025-02-24
- Accession: 0000886163-25-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/886163/000088616325000003/lgnd-20250224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/886163/000088616325000003/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/886163/000088616325000003/lgnd-20250224.htm

Filed Feb 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000886163-25-000003. Last ingested by Listed: Nov 13, 2026, 16:29 ET. No prices; not investment advice.
